Does current evidence justify prostate cancer screening in Europe?
作者信息
Martin Richard M, Smith George Davey, Donovan Jenny
机构信息
Epidemiology, Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK.
出版信息
Nat Clin Pract Oncol. 2005 Nov;2(11):538-9. doi: 10.1038/ncponc0349.
Abstract
摘要
相似文献
1
Does current evidence justify prostate cancer screening in Europe?
Nat Clin Pract Oncol. 2005 Nov;2(11):538-9. doi: 10.1038/ncponc0349.
2
Screening for prostate cancer.
Ann Oncol. 1998 Dec;9(12):1289-92. doi: 10.1023/a:1008487912288.
3
Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.
Ann Oncol. 1998 Dec;9(12):1263-4. doi: 10.1023/a:1008435911379.
4
Efficacy vs effectiveness in prostate-specific antigen screening.
J Natl Cancer Inst. 2010 Mar 3;102(5):288-9. doi: 10.1093/jnci/djq002. Epub 2010 Feb 8.
5
Screening for prostate cancer.
Br J Hosp Med. 1997;58(10):484, 486.
6
Improving appropriateness of prostate-specific antigen screening.
Arch Intern Med. 2007 Dec 10;167(22):2529-30. doi: 10.1001/archinte.167.22.2529.
7
Prostate-specific antigen: a new(ish) study.
Harv Mens Health Watch. 2010 Nov;15(4):6-8.
8
What is the value of screening for prostate cancer in the US?
Nat Clin Pract Oncol. 2005 Nov;2(11):536-7. doi: 10.1038/ncponc0348.
9
[In depth analysis of 2 studies of prostate cancer screening--what makes sense?].
Praxis (Bern 1994). 2010 Feb 3;99(3):183-5. doi: 10.1024/1661-8157/a000022.
10
Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
Eur Urol. 2009 Feb;55(2):392; discussion 393. doi: 10.1016/j.eururo.2008.02.047. Epub 2008 Mar 11.
引用本文的文献
1
Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.
BJU Int. 2008 Mar;101(5):547-55. doi: 10.1111/j.1464-410X.2007.07338.x. Epub 2008 Jan 10.
2
Quantifying the role of PSA screening in the US prostate cancer mortality decline.
Cancer Causes Control. 2008 Mar;19(2):175-81. doi: 10.1007/s10552-007-9083-8. Epub 2007 Nov 20.
3
Commentary: prostate cancer is omnipresent, but should we screen for it?
Int J Epidemiol. 2007 Apr;36(2):278-81. doi: 10.1093/ije/dym049.
本文引用的文献
1
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.
JAMA. 2005 Jul 6;294(1):66-70. doi: 10.1001/jama.294.1.66.
2
Radical prostatectomy versus watchful waiting in early prostate cancer.
N Engl J Med. 2005 May 12;352(19):1977-84. doi: 10.1056/NEJMoa043739.
3
The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
J Urol. 2004 Oct;172(4 Pt 1):1297-301. doi: 10.1097/01.ju.0000139993.51181.5d.
4
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.
N Engl J Med. 2004 May 27;350(22):2239-46. doi: 10.1056/NEJMoa031918.
5
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.
J Natl Cancer Inst. 2003 Jun 18;95(12):868-78. doi: 10.1093/jnci/95.12.868.
6
Screening for prostate cancer.
Lancet. 2003 Mar 29;361(9363):1122-8. doi: 10.1016/S0140-6736(03)12890-5.
7
Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut.
BMJ. 2002 Oct 5;325(7367):740. doi: 10.1136/bmj.325.7367.740.
8
Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland.
J Urol. 2001 Dec;166(6):2189-91; discussion 2191-2. doi: 10.1016/s0022-5347(05)65532-2.
9
Comparison of trends in prostate-cancer mortality in England and Wales and the USA.
Lancet. 2000 May 20;355(9217):1788-9. doi: 10.1016/s0140-6736(00)02269-8.
10
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.
JAMA. 2000 Jan 19;283(3):354-60. doi: 10.1001/jama.283.3.354.
Zotero 插件